Open AccessA Study of Haemostatic Parameters in Patients of Chronic Myeloid Leukaemia
Author(s) -
Ankur Jain,
Naresh Gupta,
Tejinder Singh,
Sunita Agarwal
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/19185.8135
Subject(s) - medicine , imatinib mesylate , gastroenterology , partial thromboplastin time , chronic myeloid leukaemia , fibrinogen , imatinib , platelet , myeloid leukemia , immunology
Chronic Myeloid Leukaemia (CML) is characterized by derangement of various components of the haemostatic system resulting in thrombo-haemorrhagic complications. Although less common than other myeloproliferative neoplasms, derangement of various components of the haemostatic system is observed in CML. Haemostatic abnormalities have been described in relation to hyperleucostasis and drugs used to treat CML. However, the correlation between haemostatic derangements and phase of CML is unclear in the literature.